Media Center Found (699)
Array ( [cache_time] => 0 [counts_time] => 0.0060880184173584 [query_time] => 0.0035648345947266 [total_time] => 0.009652853012085 )
April 18, 2017

Yissum, société de valorisation commerciale de l'université hébraïque de Jérusalem, a généré depuis 1964 près de 2 milliards de dollars de chiffre d'affaires. Si elle a misé très tôt sur les sciences de la vie, la structure a élargi son...

More
April 6, 2017

Soy, rice and peas still dominate the plant-based protein market, but chickpeas could soon give them all a serious run for their money, predicts Israeli start-up CHiCK.P, which is seeking a strategic partner to commercialize its patent-pending...

More
April 5, 2017

Therapix Biosciences Ltd. (NASDAQ, TASE: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense agreement for Yissum Research...

More
April 5, 2017

Therapix Biosciences Ltd. (NASDAQ, TASE: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced that it has signed a sublicense agreement for Yissum Research...

More
March 15, 2017

You’re a first-time visitor to Jerusalem, what sites are likely to arouse the strongest feelings? Naturally one would be the Western Wall, but how about the Daniel Auster Garden next to city hall?
Prof. Noam Shoval, Yonatan Schvimer and Prof....

More
March 13, 2017

Intel agreed on Monday to pay $15.3 billion for Mobileye, an Israeli technology company that specializes in making sensors and cameras for autonomous cars, as the global microchip giant tries to expand its reach in the fast-growing sector.

The...

More
March 8, 2017

An Israeli initiative that empowers parents to take the reins in educating their preschoolers is now about to expand to China and South Korea.
Aiming to equip parents to become their child’s first teacher, the Home Instruction for Parents and...

More
February 19, 2017

From research to agricultural and technical innovation and liberal government policies, Israel is a central hub for advancing medical cannabis.

More
February 7, 2017

 MercuRemoval, developer of gas treatment solutions, recently announced successful results of a trial in which its technology demonstrated dramatically high efficiency in removing mercury from flue gas emission, with mercury absorption and...

More
January 16, 2017

The sleepy capital is becoming a hi-tech hub to be reckoned with.

More
January 15, 2017

TyrNovo is developing NT219, a small molecule originally developed by Dr. Hadas Reuveni and Prof. Alexander Levitzki at the Hebrew University, and exclusively licensed from Yissum, the Hebrew University Research Development Company. TyrNovo...

More
December 24, 2016

No less than 50 Israeli start ups currently develop Cannabis-related technologies, and the Hebrew University's new startup CannabiTech is here to make a change. 

More
December 12, 2016

Clinical data showed superior efficacy & similar safety of MM-II vs. standard of care (hyaluronic acid) for treatment of pain in osteoarthritis
Sun Pharma to fund further development of MM-II including completion of Phase 2 and Phase 3 clinical...

More
December 6, 2016

Nutraceutical pain reliever makes use of marijuana’s CBD compound, doesn’t make you high.
Sales based on Israeli startup Lyotropic Delivery Systems (LDS) Biotech‘s nanotechnology have started in the US. The commercial launch of its...

More
December 1, 2016

Revolutionary new technology gives cannabinoids unparalleled access to bloodstream.
Commercial launch by Ananada Scientific of HYGIA Nutrients Brand took place at the Marijuana Business Conference in Las Vegas.

More
November 27, 2016

The potential of the students' project was first identified at a science fair by Tamir Huberman a business development specialist for the university's for-profit company, Yissum, which aims to turn the best ideas originated at the university into...

More
November 16, 2016

Still controversial in the US, Israel is leading the way to develop the next generation of Medical Cannabis.
Just last month, Yissum (the technology transfer company of the Hebrew University) announced that Agrinnovation, its investment fund...

More
November 3, 2016

Atox Bio, a clinical stage company developing novel immunemodulators for critically ill patients with severe infections, today announced the independent Data Monitoring Committee (DMC) completed its pre-planned safety review of the first 50...

More
November 2, 2016

Drug now being tested causes HIV-infected cells to self-destruct without harming the rest of the body

More